News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sepragen (SPGNA) and Neugenesis Corporation Collaborate on High Throughput Production of Antibodies in Fungal Expression System


4/17/2008 9:12:29 AM

HAYWARD, Calif.--(BUSINESS WIRE)--Sepragen Corporation (OTCBB:SPGNA), and Neugenesis Corporation jointly announced their collaboration to develop a means of high throughput, low cost production of monoclonal antibodies and vaccines for pandemic flu. The collaboration would involve Neugenesis growing its proprietary Neurospora expression system in Sepragen’s proprietary solid phase bioreactor system.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES